Literature DB >> 2001143

Flavimonas oryzihabitans (Pseudomonas oryzihabitans; CDC group Ve-2) bacteremia in the immunocompromised host.

C F Decker1, G L Simon, J F Keiser.   

Abstract

Flavimonas oryzihabitans, known previously as Pseudomonas oryzihabitans, and a member of the Centers for Disease Control group Ve-2, is a gram-negative organism that has rarely been implicated as a human pathogen. Flavimonas oryzihabitans appears to be a soil and saprophytic organism that survives in moist environments and is indigenous to rice paddles. To our knowledge, only seven cases of human infection caused by this organism have been reported; they involved four patients with bacteremia and three patients with peritonitis who were receiving continuous ambulatory peritoneal dialysis. In this report, we describe three immunocompromised patients with catheter-associated bacteremia: a patient with cancer, a patient with acquired immunodeficiency syndrome, and a patient with sickle cell disease. There is emerging clinical evidence that F oryzihabitans should be recognized as an organism that is capable of causing human disease, particularly in immunocompromised patients and with the increased usage of permanent catheters.

Entities:  

Mesh:

Year:  1991        PMID: 2001143

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

1.  A rare cause of peritonitis caused by Flavimonas oryzihabitans in continuous ambulatory peritoneal dialysis (CAPD).

Authors:  Stamatina Papakonstantinou; Evangelia Dounousi; Kyriakos Ioannou; Ioannis Tsouchnikas; Apostolos Kelesidis; Nikolaos Kotzadamis; Dimitrios Tsakiris
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Unusual clinical presentation of infection due to Flavimonas oryzihabitans.

Authors:  A Giacometti; O Cirioni; M Quarta; A M Schimizzi; M S Del Prete; G Scalise
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

Review 3.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

4.  Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  An Investigation of Potential Health Risks from Zoonotic Bacterial Pathogens Associated with Farm Rats.

Authors:  Lorina Badger-Emeka; Yasmeen Al-Mulhim; Fatimah Al-Muyidi; Maram Busuhail; Salma Alkhalifah; Norah AlEid
Journal:  Environ Health Insights       Date:  2020-08-16

6.  In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

7.  Non catheter-related bacteremia caused by Pseudomonas oryzihabitans in an adolescent with chronic renal failure undergoing peritoneal dialysis.

Authors:  T Karampatakis; A Sevastidou; E Argyropoulou; N Printza; M Tsivitanidou; E Siaka
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

8.  Outbreak of pseudomonas oryzihabitans pseudobacteremia related to contaminated equipment in an emergency room of a tertiary hospital in Korea.

Authors:  Kwang-Sook Woo; Jae-Lim Choi; Bo-Ram Kim; Ji-Eun Kim; Kyeong-Hee Kim; Jeong-Man Kim; Jin-Yeong Han
Journal:  Infect Chemother       Date:  2014-03-21

9.  In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major.

Authors:  Hany M Yehia; Ebtesam M Al-Olayan; Manal F El-Khadragy; Dina M Metwally
Journal:  Int J Environ Res Public Health       Date:  2017-07-13       Impact factor: 3.390

10.  Genome Sequences of Pseudomonas oryzihabitans Phage POR1 and Pseudomonas aeruginosa Phage PAE1.

Authors:  Zoe A Dyson; Robert J Seviour; Joseph Tucci; Steve Petrovski
Journal:  Genome Announc       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.